SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-086039
Filing Date
2015-12-21
Accepted
2015-12-21 16:33:53
Documents
5
Period of Report
2015-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-25317_18k.htm 8-K 31527
2 EX-10.1 a15-25317_1ex10d1.htm EX-10.1 6384
3 EX-10.2 a15-25317_1ex10d2.htm EX-10.2 29440
4 EX-10.3 a15-25317_1ex10d3.htm EX-10.3 130133
5 GRAPHIC g253171kgi001.gif GRAPHIC 5308
  Complete submission text file 0001104659-15-086039.txt   206264
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 151299791
SIC: 2834 Pharmaceutical Preparations